GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Operating income (TTM) | 5-year CAGR | 10-year CAGR |
|---|---|---|
| −$2.5B | 19.7% | −7.6% |
| Operating income (TTM) | −$2.5B |
|---|---|
| 5-year CAGR | 19.7% |
| 10-year CAGR | −7.6% |
Operating income
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $10.0B | +503.0% |
| 2024 | $1.7B | −78.1% |
| 2023 | $7.6B | +3.8% |
| 2022 | $7.3B | −26.1% |
| 2021 | $9.9B | +143.6% |
| 2020 | $4.1B | −5.0% |
| 2019 | $4.3B | −47.7% |
| 2018 | $8.2B | −41.9% |
| 2017 | $14.1B | −19.9% |
| 2016 | $17.6B | −20.5% |
| 2015 | $22.2B | +45.4% |
| 2014 | $15.3B | +237.4% |
| 2013 | $4.5B | +12.8% |
| 2012 | $4.0B | +5.8% |
| 2011 | $3.8B | −4.4% |
| 2010 | $4.0B | +12.3% |
| 2009 | $3.5B | +31.8% |
| 2008 | $2.7B | +23.7% |
| 2007 | $2.2B | — |